See more : Signature Leisure, Inc. (SGLS) Income Statement Analysis – Financial Results
Complete financial analysis of SMS Lifesciences India Limited (SMSLIFE.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SMS Lifesciences India Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- American Medical Technologies Inc. (ADLI) Income Statement Analysis – Financial Results
- Trencor Limited (TRE.JO) Income Statement Analysis – Financial Results
- Osyka Corporation (OSKA) Income Statement Analysis – Financial Results
- Kunming Longjin Pharmaceutical Co., Ltd. (002750.SZ) Income Statement Analysis – Financial Results
- Fulcrum Therapeutics, Inc. (FULC) Income Statement Analysis – Financial Results
SMS Lifesciences India Limited (SMSLIFE.BO)
About SMS Lifesciences India Limited
SMS Lifesciences India Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers APIs in various therapeutic areas, such as antiulcer, erectile dysfunction, anti-gout, anesthesia, anti-infective, anti-obesity, antifungal, anti-convulsant, anti-emetic, ophthalmic, anti-worm, and antiemetic. It also exports its products. The company was founded in 1990 and is based in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.06B | 3.13B | 3.47B | 2.57B | 2.57B | 3.73B | 2.09B | 2.12B | 0.00 |
| Cost of Revenue | 2.10B | 2.28B | 2.60B | 1.87B | 1.98B | 3.06B | 1.72B | 1.62B | 0.00 |
| Gross Profit | 962.44M | 845.45M | 875.42M | 702.13M | 584.48M | 667.99M | 363.92M | 502.26M | 0.00 |
| Gross Profit Ratio | 31.46% | 27.05% | 25.21% | 27.27% | 22.78% | 17.90% | 17.43% | 23.66% | 0.00% |
| Research & Development | 105.47M | 34.79M | 28.75M | 19.55M | 11.39M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 493.79M | 32.40M | 26.87M | 31.13M | 21.75M | 15.49M | 12.88M | 8.59M | 18.50K |
| Selling & Marketing | 24.03M | 22.12M | 23.41M | 20.99M | 17.81M | 33.12M | 20.43M | 25.52M | 0.00 |
| SG&A | 497.50M | 54.53M | 50.28M | 52.12M | 39.57M | 48.61M | 33.31M | 34.11M | 18.50K |
| Other Expenses | 0.00 | 23.56M | 2.62M | 4.15M | 6.39M | 3.38M | 5.74M | 2.68M | 0.00 |
| Operating Expenses | 602.97M | 664.98M | 628.88M | 478.28M | 408.70M | 383.34M | 288.15M | 272.50M | 18.50K |
| Cost & Expenses | 2.70B | 2.95B | 3.23B | 2.35B | 2.39B | 3.45B | 2.01B | 1.89B | 18.50K |
| Interest Income | 1.70M | 3.95M | 3.25M | 4.28M | 2.91M | 2.43M | 2.45M | 3.58M | 0.00 |
| Interest Expense | 101.57M | 64.24M | 57.00M | 41.56M | 45.50M | 42.93M | 31.19M | 50.56M | 0.00 |
| Depreciation & Amortization | 149.38M | 107.89M | 100.06M | 78.62M | 78.62M | 63.70M | 56.93M | 55.44M | 19.00K |
| EBITDA | 349.41M | 341.76M | 489.11M | 319.58M | 276.67M | 372.62M | 162.69M | 301.71M | 0.00 |
| EBITDA Ratio | 11.42% | 10.06% | 10.27% | 12.26% | 10.54% | 9.68% | 7.30% | 13.71% | 0.00% |
| Operating Income | 359.47M | 173.38M | 225.39M | 246.94M | 134.99M | 240.16M | 34.05M | 193.24M | -18.50K |
| Operating Income Ratio | 11.75% | 5.55% | 6.49% | 9.59% | 5.26% | 6.43% | 1.63% | 9.10% | 0.00% |
| Total Other Income/Expenses | -261.01M | -180.09M | -139.18M | -255.21M | -29.10M | -30.80M | -11.80M | -45.14M | 0.00 |
| Income Before Tax | 98.47M | 165.93M | 327.31M | 195.68M | 146.68M | 253.85M | 63.97M | 184.62M | -18.50K |
| Income Before Tax Ratio | 3.22% | 5.31% | 9.42% | 7.60% | 5.72% | 6.80% | 3.06% | 8.70% | 0.00% |
| Income Tax Expense | 35.19M | 52.16M | 74.31M | 60.11M | 44.85M | 75.38M | -1.05M | 55.19M | -19.00K |
| Net Income | 90.93M | 114.63M | 253.22M | 135.57M | 101.83M | 178.47M | 65.01M | 129.43M | -18.50K |
| Net Income Ratio | 2.97% | 3.67% | 7.29% | 5.27% | 3.97% | 4.78% | 3.11% | 6.10% | 0.00% |
| EPS | 30.08 | 37.92 | 83.76 | 44.84 | 33.68 | 59.03 | 21.50 | 42.81 | -0.01 |
| EPS Diluted | 30.08 | 37.92 | 83.76 | 44.84 | 33.68 | 59.03 | 21.50 | 42.81 | -0.01 |
| Weighted Avg Shares Out | 3.02M | 3.02M | 3.02M | 3.02M | 3.02M | 3.02M | 3.02M | 3.02M | 3.03M |
| Weighted Avg Shares Out (Dil) | 3.02M | 3.02M | 3.02M | 3.02M | 3.02M | 3.02M | 3.02M | 3.02M | 3.03M |
Source: https://incomestatements.info
Category: Stock Reports